These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16027802)

  • 1. Effect of cysteine protease inhibitor Ep-475 on TNF-alpha-independent cyclophosphamide-induced apoptosis in mouse lymphosarcoma LS cells.
    Zhanaeva SY; Korolenko TA; Khoshchenko OM; Spiridonov VK; Nikolin VP; Kaledin VI
    Bull Exp Biol Med; 2005 Feb; 139(2):186-9. PubMed ID: 16027802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cystatin C and cysteine proteinases in the development of mouse LS-lymphosarcoma.
    Poteryaeva ON; Falameeva OV; Zhanaeva SY; Svechnikova IG; Korolenko TA; Kaledin VI
    Bull Exp Biol Med; 2001 Jul; 132(1):675-7. PubMed ID: 11687851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cathepsins B and L in mouse lymphosarcoma tissue under the effect of cyclophosphamide is associated with apoptosis induction and infiltration by mononuclear phagocytes.
    Zhanaeva SY; Mel'nikova EV; Trufakin VA; Korolenko TA
    Bull Exp Biol Med; 2013 Nov; 156(1):86-90. PubMed ID: 24319737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of activity of cathepsins B, L, and D in murine lymphosarcoma model at a combined treatment with cyclophosphamide and yeast polysaccharide.
    Khalikova TA; Zhanaeva SY; Korolenko TA; Kaledin VI; Kogan G
    Cancer Lett; 2005 Jun; 223(1):77-83. PubMed ID: 15890239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse lymphosarcomas sensitive and resistant to cyclophosphamide therapy: activity of cathepsins B, L, and D during various schemes of treatment with cyclophosphamide and SE-glycan.
    Usova TA; Zhanaeva SY; Kogan G; Shandula I; Korolenko TA
    Bull Exp Biol Med; 2003 Nov; 136(5):451-4. PubMed ID: 14968157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of lysosomal cysteine proteases in the estimation of the effectiveness of the antitumorigenic therapy].
    Zhanaeva SIa; D'iakov AI; Alekseenko TA; Korolenko TA
    Biomed Khim; 2009; 55(1):89-97. PubMed ID: 19351038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation.
    Afonso S; Romagnano L; Babiarz B
    Development; 1997 Sep; 124(17):3415-25. PubMed ID: 9310336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells.
    Falgueyret JP; Black WC; Cromlish W; Desmarais S; Lamontagne S; Mellon C; Riendeau D; Rodan S; Tawa P; Wesolowski G; Bass KE; Venkatraman S; Percival MD
    Anal Biochem; 2004 Dec; 335(2):218-27. PubMed ID: 15556560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors.
    Tsuchiya K; Kohda Y; Yoshida M; Zhao L; Ueno T; Yamashita J; Yoshioka T; Kominami E; Yamashima T
    Exp Neurol; 1999 Feb; 155(2):187-94. PubMed ID: 10072294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors.
    Leto G; Pizzolanti G; Tumminello FM; Gebbia N
    In Vivo; 1994; 8(2):231-6. PubMed ID: 7919127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases.
    Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB
    J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.
    Lynas JF; Hawthorne SJ; Walker B
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64.
    Navab R; Mort JS; Brodt P
    Clin Exp Metastasis; 1997 Mar; 15(2):121-9. PubMed ID: 9062388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of cathepsin L activity in newt spermatogonial apoptosis induced by prolactin.
    Fujimoto K; Yamamoto T; Kitano T; Abé S
    FEBS Lett; 2002 Jun; 521(1-3):43-6. PubMed ID: 12067723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L.
    Bocock JP; Edgell CJ; Marr HS; Erickson AH
    Eur J Biochem; 2003 Oct; 270(19):4008-15. PubMed ID: 14511383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
    Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
    Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity and concentration of cathepsin B as prognostic criteria for the development of mouse LS lymphosarcoma and Lewis lung adenocarcinoma.
    Korolenko TA; Zhyanaeva SY; Poteryaeva ON; Falameeva OV; Levina OA; Kaledin VI; Shandula I
    Bull Exp Biol Med; 2002 Apr; 133(4):392-5. PubMed ID: 12124655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions.
    Liuzzo JP; Petanceska SS; Moscatelli D; Devi LA
    Mol Med; 1999 May; 5(5):320-33. PubMed ID: 10390548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the selective and non-selective cysteine protease inhibitors on the intracellular processing of interleukin 6 by HEPG2 cells.
    Peppard JV; Knap AK
    In Vitro Cell Dev Biol Anim; 1999 Sep; 35(8):459-64. PubMed ID: 10501085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
    Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
    Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.